"Evaluating the efficacy and safety of direct oral anticoagulants compared to warfarin in very morbidly obese patients with non-valvular atrial fibrillation: A retrospective cohort study".

ABSTRACT: •DOACs are effective and safe in very morbidly obese AF patients (BMI ≥50 kg/m²).•DOACs show similar stroke and bleeding risks as warfarin in this population.•Findings support DOACs in anticoagulation guidelines for very morbidly obese patients.

SUBMITTER: Ezaldin S 

PROVIDER: S-EPMC11758958 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature